跳至主要内容
临床试验/NCT03978793
NCT03978793已完成不适用

MyTPill: A Novel Strategy to Monitor Antiretroviral Adherence Among HIV+ Prescription Opioid Users

Ohio State University1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
31
试验地点
1
主要终点
Dried blood spots

研究概览

简要总结

This study compares several different antiretroviral adherence measures, including digital pills, in HIV+ individuals who are maintained on opioid analgesics.

详细描述

This study compares digital pills, electronic pill bottles, self-report, and dried blood spots, in measuring adherence to antiretroviral medications containing emtricitabine and tenofovir.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV+, Viral load >200copies/mL, on single pill containing TDF/FTC, receiving prescription for opioid analgesics

排除标准

  • Severe renal or hepatic disease
  • Hypersensitivity to silver, magnesium, or zinc following oral use
  • Pregnancy
  • non-English speaking
  • History of Crohn's disease or Ulcerative Colitis
  • History of bowel surgery, gastric bypass, or bowel stricture
  • History of gastrointestinal malignancy or radiation to the abdomen.

结局指标

主要结局

Dried blood spots

时间窗: six months

Measurement of dried blood spots for TDF/FTC concentrations

Adherence per two different electronic adherence measures

时间窗: Six months

Secondary outcomes are the identification of multi-level factors that are prevalent in the target population most closely linked to ART non-adherence and EAM non-adherence.

次要结局

  • Pill counts(Six months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Edward Boyer

Professor

Ohio State University

研究点 (1)

Loading locations...

相似试验